ALEVIN THERAPEUTICS LIMITED

CB22 5HX (East of England)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£259,220

Nov 21 - Apr 22

Targeting neglected kinases for new breast cancer therapies

Innovate UK award to STINGRAY BIO LIMITED and Jeffrey Roix

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}